Literature DB >> 2157302

Duration of chemotherapy in small cell lung cancer.

S G Spiro1, R L Souhami.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2157302      PMCID： PMC475628          DOI： 10.1136/thx.45.1.1

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

1.  Small cell lung cancer. Complete remission and improved survival.

Authors:  F A Greco; R L Richardson; J D Snell; S L Stroup; R K Oldham
Journal:  Am J Med       Date:  1979-04       Impact factor: 4.965

2.  Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.

Authors:  R Feld; W K Evans; G DeBoer; I C Quirt; F A Shepherd; J L Yeoh; J F Pringle; D G Payne; J G Herman; D Chamberlain
Journal:  J Clin Oncol       Date:  1984-04       Impact factor: 44.544

3.  Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.

Authors:  M C Perry; W L Eaton; K J Propert; J H Ware; B Zimmer; A P Chahinian; A Skarin; R W Carey; H Kreisman; C Faulkner
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

4.  Long-term survival in small-cell carcinoma of the lung: a population experience.

Authors:  S Davis; P W Wright; S F Schulman; D Scholes; D Thorning; S Hammar
Journal:  J Clin Oncol       Date:  1985-01       Impact factor: 44.544

5.  Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer.

Authors:  K Osterlind; H H Hansen; M Hansen; P Dombernowsky
Journal:  J Clin Oncol       Date:  1986-07       Impact factor: 44.544

6.  Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.

Authors:  S G Spiro; R L Souhami; D M Geddes; C M Ash; H Quinn; P G Harper; J S Tobias; M Partridge; D Eraut
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640
  6 in total
  6 in total

Review 1.  Management of lung cancer.

Authors:  A Melville; A Eastwood
Journal:  Qual Health Care       Date:  1998-09

2.  Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.

Authors:  P Collard; P Weynants; C Francis; D O Rodenstein
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

3.  Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.

Authors:  D C Weir; R I Gove; A S Robertson; P S Burge
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

4.  Primary tracheal tumours: a national survey.

Authors:  C M Gelder; M R Hetzel
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

5.  Quality and cost in the palliative care of cancer.

Authors:  B W Hancock
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

6.  A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.

Authors:  N M Bleehen; D J Girling; D Machin; R J Stephens
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.